New patent expiration for Merck Sharp drug JANUMET

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for JANUMET
Annual Drug Patent Expirations for JANUMET

Janumet is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from two suppliers. There are four patents protecting this drug and three Paragraph IV challenges.

JANUMET drug price trends.

Drug patent litigation for JANUMET.

The generic ingredient in JANUMET is metformin hydrochloride; sitagliptin phosphate. Two suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; sitagliptin phosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top